Team

Our People

Rinascera brings together company-building, clinical, translational, and strategic finance expertise to advance transformative therapies for patients living with rare genetic skin diseases.

Nichola Eliovits

Chief Executive Officer & Co-founder

Max Dawson

Chief Operating Officer & Co-founder

Karl Beutner, M.D., Ph.D.

Executive Medical Advisor & Co-founder

Salvador Rico, M.D., Ph.D.

Strategic Medical Advisor

Mark de Souza, Ph.D.

Strategic Advisor

Ravi Pandrapragada

Senior Vice President of Small Molecule CMC & Non-Clinical

Ramesh Putheti, Ph.D.

Director of Analytical Development

Ted Fox, Ph.D.

Vice President of Protein Engineering

Kelly Neelon, Ph.D.

Strategic Biologics CMC Advisor

Karl Beutner Jr.

Vice President of Translational Medicine

Nikola Jovanovic

Director of Biostatistics

Moung Saelee

Clinical Trial Manager

Colleen Johnson

Strategic Non-Clinical Advisor

John Vittoria

Vice President of Finance & Corporate Controller

Bhanu Sakhamuri

Chief of Staff

Zack Armen

Business Development Advisor

Board of Directors

Chinmay Shukla

Senior Vice President, Strategic Finance, BridgeBio

Dan Yadegar, M.D.

Managing Partner, Double Point Ventures

Karl Beutner, M.D., Ph.D.

Executive Medical Advisor & Co-founder

Nichola Eliovits

Chief Executive Officer & Co-founder